CLINICAL_TRIALS
trial_result
· 2013-06-20
Clinical Trial Update: Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Summary
A Mayo Clinic-sponsored Phase 1/2 trial evaluating secretin (ChiRhoStim) perfusion for pancreatic cancer was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-06-20